![Handbook of Endocannabinoid Function in the Central Nervous System Cover Image](/image.aspx?imagepath="{0}"&width=175&print=true/notavail3.gif)
|
| Available: 0 |
| Tentative Price:$299.00 |
|
|
| Edition: | 1st |
| Publisher: | Academic Press, Incorporated |
| ISBN: | 0-443-13908-3 (0443139083) |
| ISBN-13: | 978-0-443-13908-6 (9780443139086) |
| Binding: | Hardcover |
| Copyright: | 2025 |
| Weight: | 0.00 Lbs. |
| Pages: | 500 |
| Subject Class: | NEU (Neurology and Neuroscience) |
| Remarks: | This Title is Not Yet Published, Scheduled to Release 11/01/25 |
| Return Policy: | Returns accepted up to 90 days provided no other recalls or return restrictions apply. |
|
|
| |
| Abstract: | Handbook of Endocannabinoid Function in the Central Nervous System offers a comprehensive, interdisciplinary approach to understanding the role of the endocannabinoid system in the functions of the central nervous system. In recent years, brain endocannabinoids have emerged as key modulators of brain function and behavior; endocannabinoids are now considered and used for the development of selective and specific compounds able to treat several CNS diseases and conditions. This new volume brings together the most influential and internally recognized experts in the field to provide a detailed overview of physiological and pathophysiological roles of endocannabinoids in CNS activity. The book begins by covering the history, functional anatomy, and neurophysiology of the endocannabinoid system, moving on to assess endocannabinoid roles across human lifespans and in behavioral control. The final sections of the book explore the use of endocannabinoids in psychiatric and neurological disorders. is a vital resource for neuroscientists, neuropharmacologists, and neuropathologists, as well as any researcher seeking detailed discussions of brain endocannabinoid functions. Presents a new volume in the Handbook of Behavioral Neuroscience seriesExamines endocannabinoid use and function in psychiatric disorders such as anxiety, depression, substance abuse, and moreAssesses the use of endocannabinoids in treating mental disorders, including Parkinsons and AlzheimersDiscusses preclinical to clinical levels of investigation |
|
|